Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade

Clinical and molecular hepatology

Volumn 19, Issue 3, 2013, Pages 195-209

  Yim, Hyung J oon ^a   Hwang, Seong G yu ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Antiviral resistance; Chronic hepatitis B; Hepatitis B virus; Nucleoside analogue; Nucleotide analogue; Treatment

Indexed keywords

ADENINE; ANTIVIRUS AGENT; NUCLEOSIDE; PHOSPHONIC ACID DERIVATIVE; TENOFOVIR;

ANALOGS AND DERIVATIVES; ANTIVIRAL RESISTANCE; CHEMISTRY; COMBINATION DRUG THERAPY; DRUG EFFECTS; GENETICS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMAN; MUTATION; VIRUS REPLICATION;

ADENINE; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MUTATION; NUCLEOSIDES; ORGANOPHOSPHONATES; TENOFOVIR; VIRUS REPLICATION;

EID: 84894121497     PISSN: None     EISSN: 2287285X     Source Type: Journal    
DOI: 10.3350/cmh.2013.19.3.195     Document Type: Review

References (0)